![](/img/cover-not-exists.png)
Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule
Heidi Hörig, David S. Lee, William Conkright, Joe Divito, Henry Hasson, Michelle LaMare, Audrey Rivera, David Park, John Tine, Ken Guito, Kwong Wong-Yok Tsang, Jeffrey Schlom, Howard L. KaufmanVolume:
49
Language:
english
Pages:
11
DOI:
10.1007/s002620000146
Date:
October, 2000
File:
PDF, 184 KB
english, 2000